Skip to content

Petros Pharmaceuticals, Inc.: 10-Q filed 2022-08-12

What Petros Pharmaceuticals, Inc. reported in its quarterly report filed 2022-08-12 (fiscal Q2 2022): 43 published measures, 123 facts as tagged in accession 0001410578-22-002435.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-12
Fiscal period
fiscal Q2 2022
Accession
0001410578-22-002435 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Petros Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3051,049,941USD
At 2021-12-3167,390,058USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-3016,832,900USD
At 2021-12-3131,845,094USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-3034,217,041USD
At 2022-03-3135,726,568USD
At 2021-12-3135,544,964USD
At 2021-06-3019,490,727USD
At 2021-03-3120,923,140USD
At 2020-12-3117,469,052USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3013,295,089USD
At 2021-12-3123,847,572USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,811,792USD91
2022-01-01 to 2022-06-30-1,986,016USD181
2021-04-01 to 2021-06-30-2,112,917USD91
2021-01-01 to 2021-06-30896,164USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-9,475,509USD181
2021-01-01 to 2021-06-30-2,346,366USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-04-01 to 2022-06-304,186,516USD91
2022-01-01 to 2022-06-306,651,685USD181
2021-04-01 to 2021-06-302,457,649USD91
2021-01-01 to 2021-06-306,533,255USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,076,974USD181
2021-01-01 to 2021-06-30-3,762,151USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-72,674,836USD
At 2021-12-31-70,688,820USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3020,684,723shares91
2022-01-01 to 2022-06-3020,684,723shares181
2021-04-01 to 2021-06-309,802,309shares91
2021-01-01 to 2021-06-309,777,834shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-04-01 to 2022-06-3020,684,723shares91
2022-01-01 to 2022-06-3020,684,723shares181
2021-04-01 to 2021-06-309,802,309shares91
2021-01-01 to 2021-06-309,779,335shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.09USD/shares91
2022-01-01 to 2022-06-30-0.1USD/shares181
2021-04-01 to 2021-06-30-0.22USD/shares91
2021-01-01 to 2021-06-300.09USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.09USD/shares91
2022-01-01 to 2022-06-30-0.1USD/shares181
2021-04-01 to 2021-06-30-0.22USD/shares91
2021-01-01 to 2021-06-300.09USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-04-01 to 2021-06-306,700USD91
2021-01-01 to 2021-06-306,700USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-3044,287USD
At 2021-12-3149,397USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-04-01 to 2022-06-30302,265USD91
2022-01-01 to 2022-06-30658,093USD181
2021-04-01 to 2021-06-30590,502USD91
2021-01-01 to 2021-06-30937,709USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,661,420USD91
2022-01-01 to 2022-06-30-2,142,618USD181
2021-04-01 to 2021-06-30-4,280,692USD91
2021-01-01 to 2021-06-30-6,478,199USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-3022,853,237USD
At 2021-12-3130,542,695USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-307,376,848USD
At 2021-12-3130,980,076USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-06-3022,176,519USD
At 2021-12-3125,293,149USD
At 2020-12-3132,160,919USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-06-305,747,884USD
At 2021-12-312,455,386USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-305,198,716USD91
2022-01-01 to 2022-06-307,672,743USD181
2021-04-01 to 2021-06-306,345,047USD91
2021-01-01 to 2021-06-3011,974,774USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-06-301,908,857USD
At 2021-12-31519,649USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-303,537,296USD91
2022-01-01 to 2022-06-305,530,125USD181
2021-04-01 to 2021-06-302,064,355USD91
2021-01-01 to 2021-06-305,496,575USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-04-01 to 2022-06-303,216,604USD91
2022-01-01 to 2022-06-307,114,342USD181
2021-04-01 to 2021-06-304,116,173USD91
2021-01-01 to 2021-06-307,997,890USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30421,242USD91
2022-01-01 to 2022-06-30826,602USD181
2021-04-01 to 2021-06-30500,046USD91
2021-01-01 to 2021-06-30519,227USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3020,684,723shares
At 2021-12-3120,684,723shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-06-3013,295,089USD
At 2021-12-3123,847,572USD
At 2021-06-3011,031,177USD
At 2020-12-3117,139,694USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-30106,889,809USD
At 2021-12-31106,231,716USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-06-30418,779USD
At 2021-12-31475,557USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-06-30469,570USD
At 2021-12-31530,597USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-06-3022,176,519USD
At 2021-12-3125,293,149USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-06-30336,109USD
At 2021-12-31405,018USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-304,007,928USD
At 2021-12-3111,957,384USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-06-301,901,407USD
At 2021-12-313,720,088USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,811,792USD91
2022-01-01 to 2022-06-30-1,986,016USD181
2021-04-01 to 2021-06-30-2,106,217USD91
2021-01-01 to 2021-06-30902,864USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,986,016USD181
2021-01-01 to 2021-06-30896,164USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,560,870USD91
2022-01-01 to 2022-06-303,121,740USD181
2021-04-01 to 2021-06-301,728,828USD91
2021-01-01 to 2021-06-303,457,657USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-06-30153,026USD181
2021-01-01 to 2021-06-30309,497USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2022-04-01 to 2022-06-3046,935USD91
2022-01-01 to 2022-06-3093,870USD181
2021-04-01 to 2021-06-3045,942USD91
2021-01-01 to 2021-06-3091,844USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-303,185,558USD181
2021-01-01 to 2021-06-30-3,114,312USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,374,350USD181
2021-01-01 to 2021-06-30-710,496USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-2,653,421USD181
2021-01-01 to 2021-06-30-3,011,666USD181

Inspect the source

Entity
Petros Pharmaceuticals, Inc. / CIK 0001815903
Captured
2026-09-19T11:21:34.055Z
SEC response SHA-256
ce09757d7cf519fba34350164d20de41c934904fb0775c7180c184a51b39c633

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001815903.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))